格隆汇9月11日丨劲方医药-B(02595.HK)发布公告，公司拟全球发售7760万股H股(视乎发售量调整权及超额配股权行使与否而定)，中国香港发售股份776万股，国际发售股份6984万股；2025年9月11日至9月16日招股；发售价将为每股发售股份20.39港元，每手买卖单位为200股，中信证券为独家保荐人；预期股份将于2025年9月19日开始在联交所买卖。
责任编辑：栎树
格隆汇9月11日丨劲方医药-B(02595.HK)发布公告，公司拟全球发售7760万股H股(视乎发售量调整权及超额配股权行使与否而定)，中国香港发售股份776万股，国际发售股份6984万股；2025年9月11日至9月16日招股；发售价将为每股发售股份20.39港元，每手买卖单位为200股，中信证券为独家保荐人；预期股份将于2025年9月19日开始在联交所买卖。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.